{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:22Z","timestamp":1792783162532,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Yunnan Province Science and Technology Department of traditional Chinese medicine application basic research joint special project","award":["202101AZ070001-169"],"award-info":[{"award-number":["202101AZ070001-169"]}],"id":[{"id":"https:\/\/ror.org\/03whqdf70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Yunnan Province Science and Technology Department of traditional Chinese medicine application basic research joint special youth project","award":["202101AZ070001-295"],"award-info":[{"award-number":["202101AZ070001-295"]}],"id":[{"id":"https:\/\/ror.org\/03whqdf70","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05684-x","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T09:17:17Z","timestamp":1786094237000},"page":"4629-4643","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IGF2BP3 promotes early angiogenesis in pulmonary fibrosis by stabilizing HIF-1\u03b1"],"prefix":"10.1007","volume":"481","author":[{"given":"Chunyan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqing","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"5684_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cells11132095","author":"P Confalonieri","year":"2022","unstructured":"Confalonieri P, Volpe MC, Jacob J et al (2022) Regeneration or repair? The role of alveolar epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis (IPF). Cells. https:\/\/doi.org\/10.3390\/cells11132095","journal-title":"Cells"},{"issue":"1","key":"5684_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12931-021-01791-z","volume":"22","author":"TM Maher","year":"2021","unstructured":"Maher TM, Bendstrup E, Dron L et al (2021) Global incidence and prevalence of idiopathic pulmonary fibrosis. Respir Res 22(1):197","journal-title":"Respir Res"},{"issue":"2","key":"5684_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/crj.13466","volume":"16","author":"DS Glass","year":"2022","unstructured":"Glass DS, Grossfeld D, Renna HA et al (2022) Idiopathic pulmonary fibrosis: Current and future treatment. Clin Respir J 16(2):84\u201396","journal-title":"Clin Respir J"},{"key":"5684_CR4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00230-2018","author":"KR Flaherty","year":"2018","unstructured":"Flaherty KR, Fell CD, Huggins JT et al (2018) Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.00230-2018","journal-title":"Eur Respir J"},{"issue":"2","key":"5684_CR5","first-page":"197","volume":"46","author":"Y Wu","year":"2023","unstructured":"Wu Y, Zhang J, Zheng JX (2023) [Angiogenesis and pulmonary fibrosis]. Zhonghua Jie He He Hu Xi Za Zhi 46(2):197\u2013202","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"7","key":"5684_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/thx.2003.009860","volume":"59","author":"NR Simler","year":"2004","unstructured":"Simler NR, Brenchley PE, Horrocks AW et al (2004) Angiogenic cytokines in patients with idiopathic interstitial pneumonia. Thorax 59(7):581\u2013585","journal-title":"Thorax"},{"key":"5684_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119423","author":"X Liu","year":"2023","unstructured":"Liu X, Chen J, Chen W et al (2023) Targeting IGF2BP3 in cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24119423","journal-title":"Int J Mol Sci"},{"key":"5684_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010599","author":"HJ Yeo","year":"2024","unstructured":"Yeo HJ, Ha M, Shin DH et al (2024) Development of a novel biomarker for the progression of idiopathic pulmonary fibrosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25010599","journal-title":"Int J Mol Sci"},{"key":"5684_CR9","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.162060","author":"D Song","year":"2023","unstructured":"Song D, Shang J, Long Y et al (2023) Insulin-like growth factor 2 mRNA-binding protein 3 promotes kidney injury by regulating \u03b2-catenin signaling. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.162060","journal-title":"JCI Insight"},{"issue":"1","key":"5684_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13046-020-01714-8","volume":"39","author":"Z Yang","year":"2020","unstructured":"Yang Z, Wang T, Wu D et al (2020) RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer. J Exp Clin Cancer Res 39(1):203","journal-title":"J Exp Clin Cancer Res"},{"key":"5684_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/biom14121592","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Wang D, Xu R et al (2024) The physiological functions and therapeutic potential of hypoxia-inducible factor-1\u03b1 in vascular calcification. Biomolecules. https:\/\/doi.org\/10.3390\/biom14121592","journal-title":"Biomolecules"},{"key":"5684_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cells11193014","author":"Y Romero","year":"2022","unstructured":"Romero Y, Balderas-Mart\u00ednez YI, Vargas-Morales MA et al (2022) Effect of hypoxia in the transcriptomic profile of lung fibroblasts from idiopathic pulmonary fibrosis. Cells. https:\/\/doi.org\/10.3390\/cells11193014","journal-title":"Cells"},{"issue":"3","key":"5684_CR13","doi-asserted-by":"publisher","first-page":"L249","DOI":"10.1152\/ajplung.00258.2015","volume":"310","author":"AJ Bryant","year":"2016","unstructured":"Bryant AJ, Carrick RP, Mcconaha ME et al (2016) Endothelial HIF signaling regulates pulmonary fibrosis-associated pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 310(3):L249\u2013L262","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"8","key":"5684_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.70032","volume":"27","author":"C Yang","year":"2025","unstructured":"Yang C, Liu Q, Chen B et al (2025) TRIM34-mediated ubiquitination and degradation of HIF-1A regulates glycolysis in endothelial cells, inhibits angiogenesis, and relieves the progression of lung fibrosis. J Gene Med 27(8):e70032","journal-title":"J Gene Med"},{"key":"5684_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.711207","volume":"11","author":"L Jiang","year":"2021","unstructured":"Jiang L, Li Y, He Y et al (2021) Knockdown of m6A reader IGF2BP3 inhibited hypoxia-induced cell migration and angiogenesis by regulating hypoxia inducible factor-1\u03b1 in stomach cancer. Front Oncol 11:711207","journal-title":"Front Oncol"},{"issue":"04","key":"5684_CR16","first-page":"86","volume":"21","author":"B Chen","year":"2024","unstructured":"Chen B, Yang C, Fu Y (2024) [The impact of the Tianlongjie treatment plan on the pulmonary function and serum sialylated carbohydrate antigen-6 and chemokine-18 levels of patients with advanced idiopathic pulmonary interstitial fibrosis]. Chin J Pharm Affairs 21(04):86\u201390","journal-title":"Chin J Pharm Affairs"},{"issue":"02","key":"5684_CR17","first-page":"636","volume":"40","author":"D Yuan","year":"2025","unstructured":"Yuan D, Luo T, Chen B et al (2025) [The effect of Tianlongjie on vascular remodeling in rats with pulmonary interstitial fibrosis induced by bleomycin]. Chin J Traditional Chin Med 40(02):636\u2013641","journal-title":"Chin J Traditional Chin Med"},{"issue":"1","key":"5684_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1465-9921-14-56","volume":"14","author":"YY Wan","year":"2013","unstructured":"Wan YY, Tian GY, Guo HS et al (2013) Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats. Respir Res 14(1):56","journal-title":"Respir Res"},{"key":"5684_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep27911","volume":"6","author":"Y Li","year":"2016","unstructured":"Li Y, Zeng Z, Cao Y et al (2016) Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1\/2 and NF-\u03baB signaling pathways. Sci Rep 6:27911","journal-title":"Sci Rep"},{"key":"5684_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/5573353","volume":"2024","author":"S Ge","year":"2024","unstructured":"Ge S, Guo Z, Xiao T et al (2024) Qingfei Tongluo mixture attenuates bleomycin-induced pulmonary inflammation and fibrosis through mTOR-dependent autophagy in rats. Mediators Inflamm 2024:5573353","journal-title":"Mediators Inflamm"},{"issue":"3","key":"5684_CR21","first-page":"999","volume":"9","author":"X Huang","year":"2017","unstructured":"Huang X, Wang X, Xie X et al (2017) Kallistatin protects against bleomycin-induced idiopathic pulmonary fibrosis by inhibiting angiogenesis and inflammation. Am J Transl Res 9(3):999\u20131011","journal-title":"Am J Transl Res"},{"issue":"1","key":"5684_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s10020-024-00985-7","volume":"30","author":"J Wang","year":"2024","unstructured":"Wang J, Li Y, Deng L et al (2024) FTO suppresses cardiac fibrosis after myocardial infarction via m(6)A-mediated epigenetic modification of EPRS. Mol Med 30(1):213","journal-title":"Mol Med"},{"issue":"2","key":"5684_CR23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.5114\/fn.2023.126862","volume":"61","author":"H Zhao","year":"2023","unstructured":"Zhao H, Wang Y, Liang C et al (2023) LncRNA FOXD3-AS1\/miR-128-3p axis-mediated IGF2BP3 in glioma stimulates cancer angiogenesis and progression. Folia Neuropathol 61(2):168\u2013184","journal-title":"Folia Neuropathol"},{"key":"5684_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110727","volume":"108","author":"K Cheng","year":"2023","unstructured":"Cheng K, Liu S, Li C et al (2023) IGF2BP3\/HIF1A\/YAP signaling plays a role in driving acute-on-chronic liver failure through activating hepatocyte reprogramming. Cell Signal 108:110727","journal-title":"Cell Signal"},{"issue":"01","key":"5684_CR25","first-page":"174","volume":"39","author":"T Luo","year":"2024","unstructured":"Luo T, Yuan D, Li T et al (2024) [The effects of Longjie Capsule on \u03b1-SMA and E-Cadherin in lung fibrosis model rats]. Chin J Traditional Med 39(01):174\u2013180","journal-title":"Chin J Traditional Med"},{"key":"5684_CR26","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202503-262OC","author":"Y Fan","year":"2017","unstructured":"Fan Y, Bao H, Pimple P et al (2017) Incidence rate and prevalence of idiopathic pulmonary fibrosis in the United States 2017\u20132022. Ann Am Thorac Soc. https:\/\/doi.org\/10.1513\/AnnalsATS.202503-262OC","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"5684_CR27","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1177\/0885066621989244","volume":"37","author":"M Schrader","year":"2022","unstructured":"Schrader M, Sathananthan M, Jeganathan N (2022) Patients with idiopathic pulmonary fibrosis admitted to the ICU with acute respiratory failure-a reevaluation of the risk factors and outcomes. J Intensive Care Med 37(3):342\u201351","journal-title":"J Intensive Care Med"},{"issue":"22","key":"5684_CR28","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"TE King Jr","year":"2014","unstructured":"King TE jr., Bradford WZ, Castro-Bernardini S et al (2014) A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 370(22):2083\u201392","journal-title":"N Engl J Med"},{"issue":"3","key":"5684_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1136\/thx.18.3.225","volume":"18","author":"M Turner-Warwick","year":"1963","unstructured":"Turner-Warwick M (1963) Precapillary systemic-pulmonary anastomoses. Thorax 18(3):225\u2013237","journal-title":"Thorax"},{"issue":"6","key":"5684_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.patbio.2014.07.006","volume":"62","author":"DM Smadja","year":"2014","unstructured":"Smadja DM, Nunes H, Juvin K et al (2014) Increase in both angiogenic and angiostatic mediators in patients with idiopathic pulmonary fibrosis. Pathol Biol (Paris) 62(6):391\u2013394","journal-title":"Pathol Biol (Paris)"},{"issue":"46","key":"5684_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401399","volume":"11","author":"Y Lu","year":"2024","unstructured":"Lu Y, Zhu J, Zhang Y et al (2024) Lactylation-driven IGF2BP3-mediated serine metabolism reprogramming and RNA m6A-modification promotes lenvatinib resistance in HCC. Adv Sci (Weinh) 11(46):e2401399","journal-title":"Adv Sci (Weinh)"},{"issue":"9","key":"5684_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107598","volume":"300","author":"Y Cai","year":"2024","unstructured":"Cai Y, Zhou J, Xu A et al (2024) N6-methyladenosine triggers renal fibrosis via enhancing translation and stability of ZEB2 mRNA. J Biol Chem 300(9):107598","journal-title":"J Biol Chem"},{"issue":"8","key":"5684_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1793","volume":"14","author":"X Li","year":"2024","unstructured":"Li X, Li Y, Zhang W et al (2024) The IGF2BP3\/Notch\/Jag1 pathway: a key regulator of hepatic stellate cell ferroptosis in liver fibrosis. Clin Transl Med 14(8):e1793","journal-title":"Clin Transl Med"},{"issue":"5","key":"5684_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70356","volume":"97","author":"X Xu","year":"2025","unstructured":"Xu X, Zhang Y, Wu S et al (2025) Hepatitis B virus promotes angiogenesis in hepatocellular carcinoma by increasing m6A modification of VEGFA mRNA via IGF2BP3. J Med Virol 97(5):e70356","journal-title":"J Med Virol"},{"key":"5684_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156343","volume":"136","author":"M Xu","year":"2025","unstructured":"Xu M, Guo Y, Wang F et al (2025) Enterolactone combined with m6A reader IGF2BP3 inhibits malignant angiogenesis and disease progression in ovarian cancer. Phytomedicine 136:156343","journal-title":"Phytomedicine"},{"issue":"10","key":"5684_CR36","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1111\/jcmm.17295","volume":"26","author":"H Deng","year":"2022","unstructured":"Deng H, Tian X, Sun H et al (2022) Calpain-1 mediates vascular remodelling and fibrosis via HIF-1\u03b1 in hypoxia-induced pulmonary hypertension. J Cell Mol Med 26(10):2819\u20132830","journal-title":"J Cell Mol Med"},{"key":"5684_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjae021","author":"P Yan","year":"2024","unstructured":"Yan P, Yang K, Xu M et al (2024) CCT6A alleviates pulmonary fibrosis by inhibiting HIF-1\u03b1-mediated lactate production. J Mol Cell Biol. https:\/\/doi.org\/10.1093\/jmcb\/mjae021","journal-title":"J Mol Cell Biol"},{"key":"5684_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073331","author":"G Epstein Shochet","year":"2021","unstructured":"Epstein Shochet G, Bardenstein-Wald B, Mcelroy M et al (2021) Hypoxia inducible factor 1A supports a pro-fibrotic phenotype loop in idiopathic pulmonary fibrosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22073331","journal-title":"Int J Mol Sci"},{"issue":"05","key":"5684_CR39","first-page":"540","volume":"21","author":"B Chen","year":"2024","unstructured":"Chen B, Yuan D, Fu Y (2024) [The effect of Yunyao Tianlongjie staged intervention on lung tissue remodeling and pulmonary function in rats with pulmonary fibrosis]. Chin Drug Monit 21(05):540\u2013546","journal-title":"Chin Drug Monit"},{"issue":"10","key":"5684_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-104914","volume":"15","author":"LC Sia","year":"2025","unstructured":"Sia LC, Amanda G, B\u0105czek K et al (2025) Gender differences in clinical features, comorbidities and prognostic outcomes in idiopathic pulmonary fibrosis-a retrospective cohort analysis from the British Thoracic Society Interstitial Lung Disease Registry. BMJ Open 15(10):e104914","journal-title":"BMJ Open"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05684-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05684-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05684-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:45:22Z","timestamp":1791186322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05684-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":40,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["5684"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05684-x","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental protocols were approved by the Animal Ethics Review Committee of Yunnan University of Traditional Chinese Medicine; the approval number is R-062021LH-073. The animal procedures were carried out adhered to the ARRIVE guidelines 2.0.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}